
Treatment Options for Relapsed/Refractory DLBCL with Dr. Elif Yilmaz
Feb 08, 2024
03:00PM - 04:00PM EST
Online Event
Dr. Elif Yilmaz will discuss treatment options for relapsed/refractory diffuse large B-cell lymphoma patients. This presentation will include some basics of DLBCL, such as statistics, staging, and explanations of what relapse and refractory mean. Dr. Yilmaz will then discuss management options available to those with R/R DLBCL. This will include individual drugs, treatment regimens, investigational products, and supportive care.
Agenda
3:00 PM
Introduction
Kat Richardson
Kat introduces the agenda of the event and featured speaker Dr. Elif Yilmaz.
3:05 PM
Presentation
Dr. Elif Yilmaz
Dr. Yilmaz shares information about treatment options for the relapsed/refractory DLBCL patient community.
3:35 PM
Questions and Answers
Audience
Type your questions in the chat and Dr. Yilmaz will answer them!

Dr. Elif Yilmaz

Kat Richardson